Results 241 to 250 of about 38,625,897 (312)

Baseline Neuroinflammation Stratifies TSPO‐PET Response to Disease‐Modifying Therapy in Multiple Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To investigate which baseline clinical and imaging characteristics best predict TSPO‐PET‐measurable reduction in glial activation following treatment of multiple sclerosis (MS), to utilize this information for designing more efficient biomarker‐based clinical trials targeting glial activation.
Marlene T. Morch, Markus Matilainen, Giulia N. Baldrighi, Marjo Nylund, Maija Saraste, Laura Airas   +5 more
wiley   +1 more source

Anti-amyloid therapies in the Brazilian public health system: challenges and barriers. [PDF]

Lancet Reg Health Am
Castilhos RM, Resende E, Studart Neto A.
europepmc   +1 more source

Modern Management of Asymptomatic Carotid Stenosis: A Meta‐Analysis of CREST‐2, SPACE‐2, and ECST‐2

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Recent randomized trials (CREST‐2, SPACE‐2, and ECST‐2) have compared carotid revascularization (carotid endarterectomy [CEA] or carotid artery stenting [CAS]) plus contemporary medical therapy (CMT) versus CMT alone in asymptomatic carotid stenosis.
Aasim Ali, Waqar Ahmed Cheema, Fiza Nisar, Muhammad Shamoon, Sameen Sarfaraz, Ahmad Butt, Muhammad Abdullah Ali, Armaghana Abdullah, Muhammad Asad Shabbir, Muhammad Talha, Hammad Azam, Aimen Anwaar Pannun, Usama Saleem, Anousha Tanveer, Mukesh Sharma   +14 more
wiley   +1 more source

What Do We Know About Hypertrophic Cardiomyopathy in Poland in the Period 2016-2021 Based on Data From the Public Health System? [PDF]

Int J Public Health
Niemiec M, Stec M, Grzybowski J, Cegłowska U, Wiśniewska A, Hałgas K, Czepczor K, Podolski M, Gruchlik B, Orzeł-Łomozik G, Cieśla D, Gąsior M, Hryniewiecki T, Leszek P, Caforio ALP, Mizia-Stec K.   +15 more
europepmc   +1 more source

Disease Course After Anti‐CD20 Discontinuation in Secondary Progressive Multiple Sclerosis—A Multicenter Long‐Term Longitudinal Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To describe long‐term outcomes after anti‐CD20 discontinuation in selected patients with secondary progressive multiple sclerosis (SPMS) who remained without subsequent disease‐modifying therapy (DMT). Methods We retrospectively analyzed data from four centers in Austria and Switzerland.
Ferdinand Otto, Dariia Kliushnikova, Richard Friedrich Radlberger, Sinan Yasaroglu, Tobias Moser, Andrea Harrer, Kitty Kratzer, Wolfgang Hitzl, Christiane Gradl, Martin Schmidauer, Patrick Roth, Harald Hegen, Peter Wipfler   +12 more
wiley   +1 more source

Profiles and outcomes of indigenous patients with chronic kidney disease in renal speciality clinics in the public health system in Queensland, Australia. [PDF]

BMC Nephrol
Hoy WE, Diwan V, Wang Z, Zhang J, Cameron A, Venuthurupalli SK, Fassett RG, Chan S, Healy HG, Tan KS, Baer R, Mallett AJ, Gray N, Mantha M, Cherian R, Mutatiri C, Madhan K, Kan G, Mitchell G, Hossain S, Wu D, Han T, Kark A, Coleman S, Titus T, Ranganathan D, Bonner A, Govindarajulu S, Brolan C, Sreedharan A, Johnson T, Williams S.   +31 more
europepmc   +1 more source

CSF Cytokine Network Organization Predicts Progression Independent of Relapse and MRI Activity in Multiple Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Progression independent of relapse activity is a major determinant of long‐term disability in multiple sclerosis, but its immunopathologic basis remains incompletely understood. We investigated whether relapse‐independent progression in radiologically stable relapsing–remitting multiple sclerosis is associated with distinct ...
Antonio Bruno, Matteo Conti, Ettore Dolcetti, Federica Azzolini, Angela Borrelli, Roberta Fantozzi, Mario Stampanoni Bassi, Giovanni Galifi, Giuseppe Maccarrone, Luca Montaguti, Marco Cervigni, Maddalena Dal Pozzo, Roberto Furlan, Annamaria Finardi, Girolama Alessandra Marfia, Marco Salvetti, Antonella Conte, Fabio Buttari, Diego Centonze, Luana Gilio   +19 more
wiley   +1 more source

Perioperative outcomes and economic impact of benign prostatic hyperplasia surgeries in Brazil's public health system. [PDF]

BMC Health Serv Res
Takemura LS, Kirche-Duarte I, de Camargo Galindo GF, Gushiken FA, Luz JSN, Cha JD, Wroclawski ML, de Alcantara Souza LV, da Silva Paiva L, Lemos GC, Bianco B, Carneiro A.   +11 more
europepmc   +1 more source

Intermediate and long-term AKI outcomes in a public health system. [PDF]

J Nephrol
Muñoz-Sánchez A, Martín-Rodríguez L, López-Sánchez P, Valdenebro M, Serrano-Salazar ML, Marques M, Portoles J.   +6 more
europepmc   +1 more source

Evaluation of health technology implementation in the Brazilian public health system: a systematic review. [PDF]

BMC Health Serv Res
Freire ML, Noronha BP, Cota G, Silva SN.
europepmc   +1 more source